Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study aims to investigate the impact of adding Ganagliflozin tablets to the current background therapy on preventing the progression of kidney disease in subjects with type 2 diabetes and chronic kidney disease. The efficacy and safety will be evaluated by comparing the effects of Ganagliflozin tablets and placebo tablets added to the current background treatment over 120 weeks
Epistemonikos ID: 38cb0bcb7062c0c6085a6e4bceaf8245c4023d90
First added on: Aug 13, 2025